BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 24897146)

  • 1. Alopecia areata universalis complicating daclizumab therapy for uveitis.
    Rosenstein AK; Machler BC; Rosenstein ED
    Cutis; 2014 May; 93(5):E13-6. PubMed ID: 24897146
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alopecia areata during etanercept therapy.
    Pan Y; Rao NA
    Ocul Immunol Inflamm; 2009; 17(2):127-9. PubMed ID: 19412875
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Alopecia areata during anti-TNF alpha therapy: Nine cases].
    Le Bidre E; Chaby G; Martin L; Perrussel M; Sassolas B; Sigal ML; Kaassis C; Lespessailles E; Nseir A; Estève E
    Ann Dermatol Venereol; 2011; 138(4):285-93. PubMed ID: 21497255
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Alopecia areata after biologic therapy: report of a case related to adalimumab].
    Neila J; Carrizosa A; Ceballos C; Camacho FM
    Actas Dermosifiliogr; 2011 Dec; 102(10):827-8. PubMed ID: 21798487
    [No Abstract]   [Full Text] [Related]  

  • 5. Treatment of alopecia areata partim universalis with efalizumab.
    Kaelin U; Hassan AS; Braathen LR; Yawalkar N
    J Am Acad Dermatol; 2006 Sep; 55(3):529-32. PubMed ID: 16908369
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alopecia areata during treatment with adalimumab: therapy with an alternative TNF-alpha inhibitor is possible.
    Zschoche C; Bidier M; Hadaschik E
    J Dtsch Dermatol Ges; 2013 May; 11(5):450-3. PubMed ID: 23279686
    [No Abstract]   [Full Text] [Related]  

  • 7. Alopecia areata during treatment of psoriasis with adalimumab and leflunomide: a case and review of the literature.
    Navarro R; Daudén E; Gallo E; Santiago Sánchez-Mateos D; García-Diez A
    Skin Pharmacol Physiol; 2012; 25(2):107-10. PubMed ID: 22301842
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alopecia areata following adalimumab.
    Kirshen C; Kanigsberg N
    J Cutan Med Surg; 2009; 13(1):48-50. PubMed ID: 19298772
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alopecia areata in patients with systemic lupus erythematosus treated with belimumab: a plausible association.
    Shamriz O; Yahia SH; Ramot Y; Agmon-Levin N; Tal Y
    Lupus; 2020 Apr; 29(4):426-430. PubMed ID: 31924144
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alopecia areata universalis elicited during treatment with adalimumab.
    Pelivani N; Hassan AS; Braathen LR; Hunger RE; Yawalkar N
    Dermatology; 2008; 216(4):320-3. PubMed ID: 18230980
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alopecia areata in a patient with psoriatic arthritis and Crohn's disease receiving etanercept.
    Costa L; Atteno M; Caso F; Scarpato L; Del Puente A; Scarpa R
    Int J Rheum Dis; 2014 Feb; 17(2):219-20. PubMed ID: 24576280
    [No Abstract]   [Full Text] [Related]  

  • 12. Alopecia areata universalis during off-label treatment with Infliximab in a patient with Behçet disease.
    Beccastrini E; Squatrito D; Emmi G; Fabbri P; Emmi L
    Dermatol Online J; 2010 Sep; 16(9):15. PubMed ID: 20875336
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immune-related alopecia (areata and universalis) in cancer patients receiving immune checkpoint inhibitors.
    Zarbo A; Belum VR; Sibaud V; Oudard S; Postow MA; Hsieh JJ; Motzer RJ; Busam KJ; Lacouture ME
    Br J Dermatol; 2017 Jun; 176(6):1649-1652. PubMed ID: 27943234
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alopecia areata developing during ustekinumab therapy: report of two cases.
    Tauber M; Beneton N; Reygagne P; Bachelez H; Viguier M
    Eur J Dermatol; 2013; 23(6):912-3. PubMed ID: 24334218
    [No Abstract]   [Full Text] [Related]  

  • 15. Alopecia areata universalis during treatment of rheumatoid arthritis with anti-TNF-alpha antibody (adalimumab).
    Chaves Y; Duarte G; Ben-Said B; Tebib J; Berard F; Nicolas JF
    Dermatology; 2008; 217(4):380. PubMed ID: 18849606
    [No Abstract]   [Full Text] [Related]  

  • 16. Recurrence of alopecia areata in a patient receiving etanercept injections.
    Posten W; Swan J
    Arch Dermatol; 2005 Jun; 141(6):759-60. PubMed ID: 15967923
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of alopecia areata universalis in a patient receiving adalimumab.
    Garcia Bartels N; Lee HH; Worm M; Burmester GR; Sterry W; Blume-Peytavi U
    Arch Dermatol; 2006 Dec; 142(12):1654-5. PubMed ID: 17179003
    [No Abstract]   [Full Text] [Related]  

  • 18. Alopecia universalis successfully treated with adalimumab.
    Gorcey L; Gordon Spratt EA; Leger MC
    JAMA Dermatol; 2014 Dec; 150(12):1341-4. PubMed ID: 25322338
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systemic treatment for alopecia areata.
    Otberg N
    Dermatol Ther; 2011; 24(3):320-5. PubMed ID: 21689241
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Recurrent uveitis and therapy with monoclonal antibody (daclizumab)].
    Hernández Garfella ML; Díaz Llopis M; Salom Alonso D; Cervera Taulet E
    Arch Soc Esp Oftalmol; 2004 Dec; 79(12):593-8. PubMed ID: 15627927
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.